Agenus Inc. (AGEN) Financials
AGEN Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 313.9 million | 462.3 million |
2023-09-30 | 335.5 million | 450.8 million |
2023-06-30 | 383.6 million | 460.4 million |
2023-03-31 | 412.9 million | 466.0 million |
AGEN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -35.2 million | 5.5 million |
2023-09-30 | -68.7 million | 5.9 million |
2023-06-30 | -48.9 million | 6.0 million |
2023-03-31 | -60.4 million | 5.5 million |
AGEN Net Income
No data available :(
AGEN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 76.1 million | - | 65.1 million |
2023-09-30 | 106.3 million | - | 75.9 million |
2023-06-30 | 157.9 million | - | 74.1 million |
2023-03-31 | 189.2 million | 12.6 million | 74.1 million |
AGEN Shares Outstanding
AGEN Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 5.2 million | 66.7 million | 21.2 million | 5.2 million |
2023-09-30 | 3.5 million | 3.4 million | 18.9 million | - |
2023-06-30 | 4.4 million | 2.5 million | 20.4 million | - |
2023-03-31 | 1.8 million | 2.6 million | 18.2 million | - |
AGEN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 83.8 million | 5.5 million |
2023-09-30 | 24.3 million | 51.7 million |
2023-06-30 | 25.3 million | 59.5 million |
2023-03-31 | 22.9 million | 59.4 million |
AGEN
Price: $11.69
52 week price:
Payout Ratio Range:
Earnings Per Share: -12.67 USD
P/E Ratio: -0.94
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 207310
Ebitda: -30.2 millionMarket Capitalization: 185.9 million